North American Nuclear Medicine Market Worth $2.7 Bn by 2024 – Exclusive Report by MarketsandMarkets™
North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period according to a new report by MarketsandMarkets™. The key factors driving the growth of this market are increasing incidence and prevalence of cancer & cardiac ailments and the initiatives to lessen the demand-supply...
Global North American nuclear medicine market : Initiatives to Lessen the Demand-Supply Gap of Mo-99
Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.
The North...
North American nuclear medicine market | Professional Analysis, Opportunities, Strategies and Growth Forecast to 2024
The report “North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT – Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) – Forecasts to 2024“, The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2...